CABA stock forecast
Our latest prediction for Cabaletta Bio Inc's stock price was made on the Oct. 24, 2022 when the stock price was at 1.73$.
In the short term (2weeks), CABA's stock price should underperform the market by -2.72%. During that period the price should oscillate between -14.62% and +9.02%.
In the medium term (3months), CABA's stock price should outperform the market by 23.78%. During that period the price should oscillate between -28.58% and +30.87%.
Get email alertsCreate a solid portfolio with CABA
About Cabaletta Bio Inc
cabaletta bio, inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered t cell therapies for patients with b cell-mediated autoimmune diseases. its proprietary technology utilizes chimeric autoantibody receptor (caar) t cells that are designed to selectively bind and eliminate b cells, which produce disease-causing autoantibodies or pathogenic b cells. the company's lead product candidate is dsg3-caart, which is in phase i clinical trial for the treatment of mucosal pemphigus vulgaris, an autoimmune blistering skin disease, and hemophilia a with factor viii alloantibodies. its product candidate pipeline also include musk-caart, a preclinical stage product to treat a subset of patients with myasthenia gravis; fviii-caart, a discovery stage product to treat a subset of patients with hemophilia a; and dsg3/1-caart, a discovery stage product for the treatment of mucocutaneous pemphigus vulgaris. cabaletta bio, inc. has a collaboration with the un
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of None$ per share.
The book value per share is 4.88$
Three months stock forecastOct. 24, 2022
Financials
Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|---|---|---|
- | - | -51M | - | -49M | - | - | - | 29M | 4.88 | - | - | - |